Perspectives for integrating Ukraine’s API and generic drug production into supply of the EU Critical Medicines List
Discover how integrating Ukraine's API and generic drug production into the EU Critical Medicines List could boost the EU's pharmaceutical supply chain. Explore Ukraine's role in enhancing drug availability, strategic benefits, and the impact of technology transfer. Learn about current capabilities, market value, and future opportunities for building a technology transfer business case in pharma
Engaging payers in the rare disease space to prepare the market environment for the entry of a gene therapy
A pharma company sought to develop a payer engagement strategy for late-stage assets targeting a rare liver disease. The company aimed to develop measures for interacting with payers and payer advisory stakeholders to advance the field before launch and formulate an engagement plan accordingly
A development partner requires market research and due diligence on manufacturers of medical products
We helped the UN lead agency identify and qualify manufacturers of medical products to meet the growing demand in procurement. We conducted market research to identify companies and performed operational, legal, and technical due diligence to evaluate companies' eligibility for supply arrangements.